EORTC AISBL / IVZW Avenue Mounierlaan, 83/11 Brussel 1200 Bruxelles • Belgie Belgique +32 2 774 16 11
Intranet • Home

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background

16041

Phase I trial of NGR-TNF administered every 3 weeks as a 1 hour intravenous infusion in patients with solid tumor.

Back to Protocol section